Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « administration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
administrated < administration < administrations  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000014 (2012) Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000022 (2011) Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000023 (2009) Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000027 (2010) Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000031 (2005) Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000033 (2010) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Noriho Sakamoto [Japon] ; Yuji Ishimatsu [Japon] ; Katsumi Eguchi [Japon]A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
000034 (2010) Masahiro Iwamoto [Japon] ; Sumiko Honma [Japon] ; Yasushi Asano [Japon] ; Seiji Minota [Japon]Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis
000066 (2013) Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000074 (2010) Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000085 (2011) Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000096 (2009) Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000150 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
000169 (2015) Yanli Zhuang [États-Unis] ; Dick E. De Vries [Pays-Bas] ; Zhenhua Xu [États-Unis] ; Stanley J. Marciniak Jr. [États-Unis] ; Dion Chen [États-Unis] ; Francisco Leon [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis]Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach
000195 (2010) Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]Biologics in children’s autoimmune disorders: efficacy and safety
000209 (2013) D. Ernst [Allemagne] ; R. E. Schmidt [Allemagne] ; T. Witte [Allemagne]Sekundäre Immundefizienz bei rheumatologischen Erkrankungen
000241 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000304 (2013) Tomokazu Nagao ; Reina Kusunoki ; Chiaki Iwamura ; Shigeto Kobayashi ; Wako Yumura ; Yosuke Kameoka [Japon] ; Toshinori Nakayama ; Kazuo Suzuki [Japon]Correlation of interleukin‐6 and monocyte chemotactic protein‐1 concentrations with crescent formation and myeloperoxidase‐specific anti‐neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti‐interleukin‐6 receptor antibody or mizoribine
000323 (2013) P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie]Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
000337 (2011) Sylvie Fabre [France]Approches pharmacologiques en immuno-rhumatologie
000419 (2013) R. Watanabe ; H. Okuno ; T. Ishii ; H. Harigae ; Y. Hirabayashi [Japon]AB0330 Long-term administration of tocilizumab increases the structural remission rate year by year and continuously inhibits radiographic progression: 3 year results from michinoku tocilizumab study group
000459 (2013) N. Mozaffarian [États-Unis] ; M. Karunaratne [États-Unis] ; V. Arora [États-Unis]SAT0444 Administration of Routine Preventative Vaccinations in Children with Juvenile Idiopathic Arthritis Receiving Adalimumab

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "administration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "administration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    administration
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021